Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

BACKGROUND: Ixekizumab improves signs/symptoms of psoriatic arthritis (PsA). We present an integrated analysis of baseline disease burden and post-baseline outcomes in ixekizumab-treated patients with enthesitis or dactylitis. METHODS: Data from SPIRIT-P1 and SPIRIT-P2 were integrated. Patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Res Ther
Hlavní autoři: Gladman, Dafna D., Orbai, Ana-Maria, Klitz, Uta, Wei, James Cheng-Chung, Gallo, Gaia, Birt, Julie, Rathmann, Suchitrita, Shrom, David, Marzo-Ortega, Helena
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350390/
https://ncbi.nlm.nih.gov/pubmed/30696483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1831-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky